Hormone Receptor Positive Tumor trials recruiting in Michigan

All Hormone Receptor Positive Tumor trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
  NCT07227831 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Michigan: Bay City, Clarkston, Detroit, Flint
• A Study of the TheraBionic P1 Device in Breast Cancer
  NCT07218432 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: Female · Michigan: Clarkston, Detroit, Farmington Hills, Flint
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
  NCT01042379 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Lansing
• Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
  NCT05735080 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
  NCT06982521 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Royal Oak